T1	Participants 355 373	attention deficits
T2	Participants 381 404	moderate-to-severe TBI.
T3	Participants 709 895	22 rigorously selected cases were enrolled, 13 of whom completed the trial. They were 16-42 years of age and had newly acquired attention deficits persisting for 6-34 months post-injury.